Pro-ficiency and Scarritt Group Join Forces to Create Comprehensive Solutions for Virtual Investigator Meetings and Site Initiation Visits


Pro-ficiency and Scarritt Group Inc. are pleased to announce that they have entered into a global strategic partnership, combining Pro-ficiency’s unique simulation-based trial training technology with Scarritt Group’s Virtual Conference Center to offer a comprehensive solution for Virtual Investigator Meetings and Site Initiation Visits.

“Since the pandemic, pharmaceutical sponsors have been struggling to replace traditional face-to-face investigator meetings with a virtual solution. To do this effectively, you need to carefully consider all the objectives of an IM and what blend of technology does the best job with each of those objectives,” said Pro-ficiency co-CEO Dave Hadden. “There are three main objectives of an IM: train your investigators, meet them to develop a solid working relationship with them, and build interest and excitement about your study. Virtual-IM™ provides a best-in-class offer that satisfies those three objectives.”

After the training and investigator meeting is conducted, Scarritt and Pro-ficiency offer Virtual-SIV™ which manages all site onboarding activities such as staff training and site inspection.

The combined Scarritt and Pro-ficiency solution offers the best-in-class approach for each of these objectives. Pro-ficiency’s Virtual Study Trainer uses advanced simulation training technology to assess and train investigators to the maximum performance levels possible, and all online and asynchronously. “When the investigator comes to Scarritt’s Virtual Conference Center for the live component of the meeting, we already know their strengths and knowledge gaps so the study teams can focus the meeting agenda on the areas with the highest risk,” commented Adrienne Williams, Scarritt CEO. “Engaging investigators online is hard when you lose the face-to-face component. Our VCC facilitates face-to-face interactions between investigators and study team members to develop those connections. We also use proprietary AI-avatars and live conference facilitators to keep the investigators interested and engaged in the meeting.”

Scarritt and Pro-ficiency have been utilizing these virtual products for over five years. This is not new to them and they have had time to perfect the approach. Together, the companies have conducted over 2,000 virtual investigator meetings and provided virtual study training to over 120,000 investigators.

About Scarritt Group

Scarritt Group is an international meeting planning and logistics company that focuses on providing clinical meetings. Scarritt Group was founded in 1999 and has substantial knowledge in meeting planning for many different industries. Learn more at

About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at

Source: Pro-ficiency LLC

ACRP-Pro-ficiency Partnership

FOR IMMEDIATE RELEASE: February 11, 2020

Jeremy Glunt
+ 1.703.258.3506
[email protected]

ACRP, Pro-ficiency Partnership Signals New Era in Clinical Research Workforce Competency Development


Washington, DC – Clinical research workforce development is taking a major step into the future thanks to a partnership announced today by the Association of Clinical Research Professionals (ACRP) and Pro-ficiency.

The new partnership brings together two of the world’s leading providers of clinical research workforce development solutions, and will empower ACRP to provide a next-generation, competence-based professional development experience to its global network of 50,000-plus clinical research professionals and organizations.

“Despite the important role clinical trials play in the development of new drugs and therapies, our industry has too often and for too long approached workforce development with a ‘check box’ mentality—ensuring compliance with training requirements, but failing to adequately develop competency or raise the standard of clinical trial conduct,” says Jim Kremidas, ACRP Executive Director. “By connecting clinical research professionals and organizations with cutting-edge development programs, this partnership will usher in a new era in workforce development that will fully unlock the potential of our profession.”

The partnership pairs ACRP’s industry-leading training and development programs with Pro-ficiency’s revolutionary compliance management system that reveals key insights into team competency.

“Organizations who partner with ACRP will now have actionable data they can use to assess team competency and to make informed decisions about staff development activities with a rigorous focus on mitigating risk and addressing performance gaps,” Kremidas says. 

The Pro-ficiency compliance management system removes the mystery and challenges of staff development. With a user-friendly interface, training administrators can easily manage users, assign and track completion of development programs, and access certificates of completion required for regulatory and protocol compliance. User-specific data provided for each development program provides administrators and leadership with valuable insights into areas for additional training and risk mitigation activities. 

ACRP and Pro-ficiency will also collaborate in developing ACRP’s portfolio of competency-based simulation modules that will enable clinical trial staff to master key skills. 

“Experiential learning, or learning by doing, is the most effective way to train teams on critical processes and skills. Simulation-based training personalizes the learner experience, improving knowledge acquisition and increasing retention of key learnings,” says JoAnne Schaberick, Co-CEO of Pro-ficiency.

“By leveraging Pro-ficiency’s proven expertise developing practical, application-based learning programs that employ effective, simulation-based training methodologies, ACRP is reinventing traditional online learning in the clinical research enterprise with a focus on true competency development,” Kremidas adds.

All Posts

ACRP and Pro-ficiency will showcase the power of this new partnership at the 2020 SCOPE conference in Orlando, Florida, February 18-21.


About ACRP

In clinical research, people are everything. ACRP raises clinical research standards and accelerates careers. Better people. Better results. 


About Pro-ficiency

Pro-ficiency is a comprehensive human performance improvement system for clinical trials. Initiate trial sites faster and more efficiently and reduce protocol violations with our easy-to-use web-based platform. Learn more at

Pro-ficiency Wins the Start-Up Component of VCIC – Venture Capital Investment Competition

DURHAM, N.C., April 5, 2019 ( – Pro-ficiency, a start-up company providing a comprehensive human performance improvement system for clinical trials, has won the Venture Capital Investment Competition (VCIC) at the UNC Kenan-Flagler School of Business for the second time. The VCIC is the leading venture capital competition for business students and has been running for 21 years. The program serves 1,500 students, 150 venture capitalists and 100 entrepreneurs worldwide. Universities from around the United States and Canada sponsor student teams to compete in regional competitions, and the seven finalists compete at UNC for the championship. This year’s finalists were Acadia University, Brigham Young University, Cornell, Georgetown, Miami University, Notre Dame and Utah Valley University.

VCIC seeks to raise college students’ awareness of the venture capital process by pairing entrepreneurs with exceptional students acting as venture capitalists. Companies pitch their business ideas to a team of students. Then students select which business they want to fund. A panel of judges comprised of expert venture capitalists pick a winning team based on the quality of their due diligence and their final investment offering or “Term Sheet.” This year, BYU took home the top prize and second and third were awarded to Utah Valley and Miami University.

Pro-ficiency received five of the seven terms sheets, making it the winner of the start-up side of the competition. Dave Hadden, CEO of Pro-ficiency, says this about the program: “I love participating in this competition. I am passionate about entrepreneurship, and these outstanding students will lead many start-ups of the very near future.” Patrick Vernon, Clinical Associate Professor of Strategy and Entrepreneurship at UNC Kenan-Flagler and Director of VCIC, commented, “Dave Hadden participated in 2013 with TheraSim, and received the most terms sheets that year also. TheraSim subsequently sold to WebMD in 2014, so our students must be onto something. It is passionate, successful founders like Dave that make VCIC such a valuable learning experience.”

About Pro-ficiency

Pro-ficiency leverages simulation to provide real-world training experiences for clinical trials. Pharmaceutical Sponsors use Pro-ficiency to initiate trial sites faster and more efficiently and to
identify possible protocol deviations. With the help of Pro-ficiency, Sponsors decrease study time, lower costs, conduct early protocol feasibility, reduce patient safety risk and predict and avoid study errors.

For more information, contact:
Natalie Rosen, Public Relations Manager, (919) 245-7870, [email protected]
Source: Pro-ficiency LLC

Additional Links – Message from Pro-ficiency CEO

Related Video

About Pro-ficiency

Pro-ficiency is a simulation company focused on improving human performance in clinical trials, and
providing better education tools for patients and healthcare providers. | Media Room

Company Address

44 Court St. Suite 1217
Brooklyn, NY 11201

Pro-ficiency to Demonstrate their Virtual Reality System for Clinical Trials at SCOPE

Pro-ficiency, the simulation training company for clinical trials, will be at the 2019 SCOPE conference in Orlando Florida.
“We are excited to demonstrate the benefits of using simulation training to improve the quality of clinical trials,” said CoCEO Dave Hadden. “Clinical operations is overdue for technology-based enhancement as research costs continue to rise.”

Pro-ficiency is based in Durham, the heart of the Research Triangle and the headquarters of large CROs, medical technology and pharmaceutical companies.
“Our sales are increasing significantly year-over-year, so pharmaceutical sponsors are seeing the value of improving the way they manage sites and investigators in the clinical trial process. It’s important for patient safety and trial efficiency that we use the best technology available” commented Laura Nufire, Pro-ficiency’s Director of Clinical Operations & Project Management.

Hadden continued, “Simulation is the gold standard for other high-risk industries like aviation, surgery and space exploration. At Pro-ficiency, we have cracked the code for bringing these benefits to clinical research and we have dozens of global studies to validate the benefits of this approach. A huge advantage to using Pro-ficiency to train investigator sites is that all staff can be trained, and at any time. The turnover rate at sites is no longer a problem, nor is bringing on additional sites during the trial. And our analytics dashboard can show the CRO/sponsor exactly how sites are doing, areas they need help with (at an individual or aggregated level), and who has or hasn’t completed the training. It’s a vast improvement over the current Investigator Meeting / eLearning model for training.”

Pro-ficiency is on the cutting edge of clinical trial technology and will be demonstrating how virtual reality can be utilized to extend their experiential learning platform even further. “Virtual Reality is closer and easier to implement than you think. It’s portable, immersive and inexpensive now,” commented Dmitri Medvedev, Director of Content Realization.
“Meetings and powerpoints just don’t stick. Introducing on-line simulation training will transform your protocol, GCP, PV and SOP training from a cost center into a powerful human performance management system,” commented CoCEO JoAnne Schaberick.
Pro-ficiency will be at Table 1 in the 2019 SCOPE Conference for Clinical Operations Executive in Orlando.

About Pro-ficiency


Pro-ficiency provides a comprehensive human performance improvement system for clinical trials. We leverage simulation to provide real-word training for sites and subjects. Pharmaceutical Sponsors use Pro-ficiency to initiate trial sites faster and more efficiently and to preempt potential protocol deviations. With the help of Pro-ficiency, sites decrease study time by as much as 30% and Sponsors lower costs, reduce meetings, conduct early protocol feasibility, and predict and avoid study errors.

Press Contact:

Natalie Rosen
Pro-ficiency, LLC
@The American Underground
201 W Main St, #100 (office) – #104
Durham, NC 27701

(919) 245-7870

  • The Pro-ficiency Advantage
  • The simulation-based training system promotes activated and “deep” learning
  • Training available at any time for any site user (and new site staff)
  • “Real-world,” simulated clinical challenges keep the learner engaged and demonstrate their understanding
  • Easily identify engaged sites and site Heroes
  • Analytics show how site staff are doing and predict error
  • FDA CFR 21 Parts 820 and 11-compliant system
  • Training audit trail and smart-certificates (expiration and renewal)
  • SOP, GCP & pharmacovigilance modules available
  • Training can easily be updated for amendments
  • Subtitles in multiple languages available as needed
  • Can replace or augment traditional Investigator Meetings

Pro-ficiency Announces Expansion of Clinical Trials Expertise

DURHAM, N.C., May 8, 2018 ( – Pro-ficiency™, the leading provider of simulation training for clinical trials, announces three new team members who bring a wealth of clinical trials experience to the team.

Chris Duncombe, AM, MD, Ph.D. – Senior Medical Writer

Dr. Chris Duncombe is a renowned global health researcher and associate professor in the department of global health at the University of Washington with 20 years of clinical trial experience. He has 42 peer-reviewed publications and has written normative guidance for the World Health Organization on the rapidly evolving concept of differentiated care within a public health approach. He has been an investigator on 41 NIH and pharma-sponsored clinical trials and was the writer of the 2010 WHO guidelines for the use of antiretroviral therapy in a public health. Dr. Duncombe joins the Pro-ficiency team as senior medical writer.

Laura Nufire, MSW, LCSW – Senior Project Manager

Ms. Nufire has worked in the clinical trials/pharmaceutical arena for more than 16 years. She spent 11 1/2 years in progressively responsible positions at Quintiles (now IQVIA), running over 16 Phase I-IV clinical trials across multiple therapeutic areas, as well as working on specialized teams to improve processes and technology. Additionally, she has direct clinical experience, having worked as a psychotherapist in a variety of settings (inpatient, outpatient, community mental health and in a university counseling program). She is known as an “out-of-the-box” thinker who has been very invested and involved in the role of technology in clinical trials. Ms. Nufire will be assuming the role of senior project manager at Pro-ficiency.

Obianuju Helen Okoye, MD, MBA, MS-EPI – Senior Staff Medical Writer

Dr. Obianuju Helen Okoye is an American public health physician/health care executive/researcher/entrepreneur with vast experience in clinical research, mental health, clinical quality, clinical medicine and public health. She has been featured on NBC News, Yahoo News and The Huffington Post, among others, and has presented at several American and international medical conferences. Her background includes being an NIH Clinical and Research Fellow at Johns Hopkins University School of Medicine and she has a plethora of clinical research experience. She has been involved in clinical research and consulting projects across the USA, on the African continent, as well as Australia. Dr. Okoye adds strong writing skills, research experience, technical assistance and capacity-building experience to the team. Dr. Okoye deepens Pro-ficiency’s bench of senior medical writers.

About Pro-ficiency

Pro-ficiency is a simulation company focused on improving human performance in clinical trials, and
providing better education tools for patients and healthcare providers. | Media Room

Company Address

44 Court St. Suite 1217
Brooklyn, NY 11201

Original Source:

Pro-ficiency Announces Software for Clinical Trial Simulation Training

DURHAM, N.C., September 5, 2017 ( – Pro-ficiency™, the leading provider of simulation training for clinical trials, announces its ProCT Enterprise Edition. “A little over a year ago, we launched the industry’s first online simulation training tool for clinical trials. Within six months of using it, we are seeing pharmaceutical sponsors replace investigator meetings with our interactive online simulation tool. Slide presentations and lectures just don’t get the results that stakeholders need. For an industry that is focused on innovation, it’s surprising that we are satisfied with using 20-year-old eLearning technology, or meetings and binders, to train personnel to run multi-million dollar studies,” commented David Hadden, Co-CEO of Pro-ficiency.

With the ProCT platform, investigators, study coordinators, and CRAs are trained on the protocol using simulations of actual study subjects. “It is learning by doing,” comments JoAnne Schaberick, Co-CEO of Pro-ficiency. “Clinical trial personnel are trained using real-life scenarios that model the decisions they will perform in the study. This type of training is more effective than traditional methods. That is why it is used to train high-value professionals such as airline pilots and astronauts.”

Pro-ficiency’s main product, ProCT, can be used to replace or supplement investigator meetings. “A key benefit of using ProCT is that it provides predictive data. We can detect and correct flaws in the protocol that would otherwise result in confusion, and we can predict errors that site staff are likely to make and correct them before they happen. This also makes site initiation faster and more accurate,” Hadden explained. “The product is like an online version of those choose-your-own-adventure books we had as kids.” He continued, “every learner makes their own choices and those choices impact the results of the simulation; learning by doing.”

Pro-ficiency’s revenue has doubled since the launch of ProCT. “We see it as a strong indicator that pharma is ready to implement modern solutions to old problems,” concluded Schaberick.


About Pro-ficiency

Pro-ficiency combines the best of simulated learning technology with the power of predictive analytics. Pro-ficiency address all aspects of health learning, including research (ProCT), patient empowerment (ProPatient) and clinical practice (ProDoctor).

ProCT provides more cost-effective, efficient and comprehensive training for investigators, monitors, CRAs, study coordinators and patients. Using the ProCT simulation platform, Pro-ficiency helps pharmaceutical companies save time and money by making their clinical trials more efficient and accurate.

Learn more at

Source: Pro-ficiency

44 Court St. Suite 1217
Brooklyn, NY 11201